date:Aug 08, 2012
High blood pressure, nausea, cerebral haemorrhage, stroke and death were among the health issues referenced. The agency warned people who might have taken it to visit a doctor.
The FSA said it was working with enforcement authorities to remove DMAA (methylhexanamine/1,3-dimethylamylamine) products from shelves, even as it confirmed that the regulatory status of the ingredient remained unresolved in the UK.
A spokesperson said that determination was in the hands of the Medicines and Healthcar